Arcellx (ACLX) Retained Earnings (2021 - 2025)
Arcellx's quarterly Retained Earnings came in at $843000.0 in Q4 2025, up 100.17% year-on-year from $421142.7 in Q4 2024, and up 100.13% quarter-over-quarter from -$667.6 million in Q3 2025.
Arcellx has reported Retained Earnings for 5 years, with the latest figure at $843000.0 in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings rose 100.17% year-over-year to $843000.0; the trailing twelve-month figure through Dec 2025 stood at $843000.0 (up 100.17% YoY), and the FY2025 full-year result was $843000.0, up 100.17% from the prior year.
- Retained Earnings for Q4 2025 stood at $843000.0, up from -$667.6 million in the prior quarter.
- The five-year high for Retained Earnings was $1.9 million in Q3 2024, with the low at -$667.6 million in Q3 2025.
- Average Retained Earnings over 5 years is -$165.1 million, with a median of -$512000.0 recorded in 2024.
- Year-over-year, Retained Earnings surged 347.51% in 2023 and slumped 90927.79% in 2024.
- Tracing ACLX's Retained Earnings over 5 years: stood at -$20000.0 in 2021, then sank by 1005.0% to -$221000.0 in 2022, then surged by 347.51% to $547000.0 in 2023, then tumbled by 90927.79% to -$496.8 million in 2024, then soared by 100.17% to $843000.0 in 2025.
- The last three Retained Earnings figures came in at $843000.0 (Q4 2025), -$667.6 million (Q3 2025), and -$611.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 843,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 843,000.00 |
| Sep 30, 2025 | -667.65 Mn |
| Jun 30, 2025 | -611.87 Mn |
| Mar 31, 2025 | 649,000.00 |
| Dec 31, 2024 | -496.83 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | -792,000.00 |
| Mar 31, 2024 | -512,000.00 |
| Dec 31, 2023 | 547,000.00 |
| Sep 30, 2023 | -409.32 Mn |
| Jun 30, 2023 | -7,000.00 |
| Mar 31, 2023 | 86,000.00 |
| Dec 31, 2022 | -221,000.00 |
| Sep 30, 2022 | -279.80 Mn |
| Jun 30, 2022 | -186.92 Mn |
| Mar 31, 2022 | -156.15 Mn |
| Dec 31, 2021 | -20,000.00 |